BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34340640)

  • 21. Case reports of neuroleptic malignant syndrome in context of quetiapine use.
    Detweiler MB; Sullivan K; Sharma TR; Kim KY; Detweiler JG
    Psychiatr Q; 2013 Dec; 84(4):523-41. PubMed ID: 23686527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M; Adityanjee ; Jampala C
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome induced by atypical antipsychotics.
    Farver DK
    Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J; Bruhn AM
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use.
    Uvais NA; Moideen S; Anver PC
    Prim Care Companion CNS Disord; 2022 Sep; 24(5):. PubMed ID: 36179364
    [No Abstract]   [Full Text] [Related]  

  • 30. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.
    Nakamura M; Yasunaga H; Miyata H; Shimada T; Horiguchi H; Matsuda S
    J Clin Psychiatry; 2012 Apr; 73(4):427-30. PubMed ID: 22154901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical neuroleptic malignant syndrome - A case report.
    Vellekkatt F; Kuppili PP; Bharadwaj B; Menon V
    Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
    Szota A; Ogłodek E; Araszkiewicz A
    Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D; Bristow MF
    Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
    [No Abstract]   [Full Text] [Related]  

  • 37. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome: two cases without muscle rigidity.
    Wong MM
    Aust N Z J Psychiatry; 1996 Jun; 30(3):415-8. PubMed ID: 8839955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
    Hatch CD; Lund BC; Perry PJ
    Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.